EUVIMEDEUVIMED entdecken
Open Access

Loss to follow-up among adults with drug-resistant TB in Papua New Guinea

F Charles, Y D Lin, J Greig, S Gurra, R Morikawa, S M Graham, A Maha

Public Health Action · 2024-09 · 14 (3) · 85-90

DOI: 10.5588/pha.24.0004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Public Health Action, online erschienen am 01.09.2024. Verfasst von F Charles und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Burnet Institute, Port Moresby, Papua New Guinea (PNG). Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

SETTING Multidrug-resistant/rifampicin-resistant TB (MDR/RR-TB) is now endemic in the National Capital District (NCD), Papua New Guinea. Loss to follow-up (LTFU) is a challenge. OBJECTIVE To evaluate and identify risk factors for LTFU, including pre-treatment LTFU, in adults with MDR/RR-TB at Port Moresby General Hospital (PMGH). DESIGN A retrospective analysis of treatment initiation in adults diagnosed with MDR/RR-TB (2018–2022) and outcomes for a cohort treated for MDR/RR-TB (2014-2019). We assessed the factors associated with LTFU using multivariate logistic regression. RESULTS Of 95 patients diagnosed with MDR/RR-TB at PMGH from 2018 to 2022, 21 (22%) were lost to follow-up before treatment. Of the 658 adults who initiated treatment for MDR/RR-TB at PMGH from 2014 to 2019, 161 (24%) were lost to follow-up during treatment. A higher proportion of patients on injectable-containing long regimens (110/404, 27%) were lost to follow-up than those on the all-oral regimen containing bedaquiline (13/66, 12%). Treatment loss to follow-up was associated with age (35–54 years age group: aOR 0.49, 95% CI 0.32–0.77; 55–75 years age group: aOR 0.42, 95% CI 0.19–0.90; compared to the 15–34 years age group), residence outside of NCD (aOR 1.79, 95% CI 1.04–3.06), and year of treatment initiation. CONCLUSION Pre-treatment LTFU requires programmatic focus. Shorter oral regimens and decentralised services may address the reasons for higher LTFU in younger people and people living outside NCD.

Schlagwörter

Stichwörter der Autor:innen

DR-TBLTFUPNGbedaquilinepre-treatmenttreatment outcomestuberculosis

Autor:innen und Institutionen

  • The Burnet Institute, Port Moresby, Papua New Guinea (PNG).
  • The Burnet Institute, Melbourne, VIC, Australia.
  • Port Moresby General Hospital, Port Moresby, PNG.
  • University of Melbourne Department of Paediatrics, Royal Children's Hospital, Melbourne, VIC, Australia.
  • National Department of Health, PNG.
  • Gulf Provincial Health Authority.

Zitieren

APA

Charles, F., Lin, Y. D., Greig, J., Gurra, S., Morikawa, R., Graham, S. M., & Maha, A. (2024). Loss to follow-up among adults with drug-resistant TB in Papua New Guinea. Public Health Action, 14(3), 85-90. https://doi.org/10.5588/pha.24.0004

Vancouver

Charles F, Lin YD, Greig J, Gurra S, Morikawa R, Graham SM, et al. Loss to follow-up among adults with drug-resistant TB in Papua New Guinea. Public Health Action. 2024;14(3):85-90. doi:10.5588/pha.24.0004

BibTeX
@article{Charles2024,
  author = {Charles, F and Lin, Y D and Greig, J and Gurra, S and Morikawa, R and Graham, S M and Maha, A},
  title = {Loss to follow-up among adults with drug-resistant TB in Papua New Guinea},
  journal = {Public Health Action},
  year = {2024},
  volume = {14},
  number = {3},
  pages = {85--90},
  doi = {10.5588/pha.24.0004}
}
Kostenlos starten →